DSI Connect

Rob Daiichi Sankyo

The rep-driven sales force arms race had come to an end and the pharmaceutical sales model needed to change. And with it, this pharmaceutical giant needed a new engagement strategy. The focus had to change from that of relationship building to one of information delivery, communicating the benefits and risks of adopting specific products and their differentials from one another.